CN111072688B - 一种头孢匹胺酸的精制方法 - Google Patents
一种头孢匹胺酸的精制方法 Download PDFInfo
- Publication number
- CN111072688B CN111072688B CN201911395128.1A CN201911395128A CN111072688B CN 111072688 B CN111072688 B CN 111072688B CN 201911395128 A CN201911395128 A CN 201911395128A CN 111072688 B CN111072688 B CN 111072688B
- Authority
- CN
- China
- Prior art keywords
- cefpiramide
- acid
- cefpiramide acid
- refining
- triethylamine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- PWAUCHMQEXVFJR-PMAPCBKXSA-N cefpiramide Chemical compound C1=NC(C)=CC(O)=C1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 PWAUCHMQEXVFJR-PMAPCBKXSA-N 0.000 title claims abstract description 93
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000007670 refining Methods 0.000 title claims abstract description 28
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 74
- -1 cefpiramide acid triethylamine salt Chemical class 0.000 claims abstract description 42
- 238000005406 washing Methods 0.000 claims abstract description 25
- 238000001035 drying Methods 0.000 claims abstract description 24
- 238000001914 filtration Methods 0.000 claims abstract description 24
- 238000002156 mixing Methods 0.000 claims abstract description 21
- 239000000706 filtrate Substances 0.000 claims abstract description 19
- 229960005446 cefpiramide Drugs 0.000 claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008213 purified water Substances 0.000 claims abstract description 15
- 238000003756 stirring Methods 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000012266 salt solution Substances 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 12
- 239000000243 solution Substances 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 7
- 238000010828 elution Methods 0.000 claims abstract description 7
- 239000012043 crude product Substances 0.000 claims abstract description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 38
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 36
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 32
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 16
- 238000002425 crystallisation Methods 0.000 claims description 15
- 230000008025 crystallization Effects 0.000 claims description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- 229960001701 chloroform Drugs 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 5
- 238000000746 purification Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 16
- 238000001816 cooling Methods 0.000 description 16
- 238000004128 high performance liquid chromatography Methods 0.000 description 15
- 229910052799 carbon Inorganic materials 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 6
- 229930186147 Cephalosporin Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940124587 cephalosporin Drugs 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003513 alkali Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003536 tetrazoles Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/12—Separation; Purification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911395128.1A CN111072688B (zh) | 2019-12-30 | 2019-12-30 | 一种头孢匹胺酸的精制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911395128.1A CN111072688B (zh) | 2019-12-30 | 2019-12-30 | 一种头孢匹胺酸的精制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111072688A CN111072688A (zh) | 2020-04-28 |
CN111072688B true CN111072688B (zh) | 2021-05-04 |
Family
ID=70319632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911395128.1A Active CN111072688B (zh) | 2019-12-30 | 2019-12-30 | 一种头孢匹胺酸的精制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111072688B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103059048A (zh) * | 2011-10-21 | 2013-04-24 | 珠海保税区丽珠合成制药有限公司 | 一种制备头孢匹胺酸的方法 |
CN103319505A (zh) * | 2013-06-07 | 2013-09-25 | 华北制药河北华民药业有限责任公司 | 结晶生产头孢匹胺钠晶体的方法 |
CN109369683A (zh) * | 2018-11-01 | 2019-02-22 | 华北制药河北华民药业有限责任公司 | 一种头孢匹胺钠的制备方法 |
CN109438477A (zh) * | 2018-11-08 | 2019-03-08 | 华北制药河北华民药业有限责任公司 | 一种头孢匹胺酸的精制方法 |
-
2019
- 2019-12-30 CN CN201911395128.1A patent/CN111072688B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103059048A (zh) * | 2011-10-21 | 2013-04-24 | 珠海保税区丽珠合成制药有限公司 | 一种制备头孢匹胺酸的方法 |
CN103319505A (zh) * | 2013-06-07 | 2013-09-25 | 华北制药河北华民药业有限责任公司 | 结晶生产头孢匹胺钠晶体的方法 |
CN109369683A (zh) * | 2018-11-01 | 2019-02-22 | 华北制药河北华民药业有限责任公司 | 一种头孢匹胺钠的制备方法 |
CN109438477A (zh) * | 2018-11-08 | 2019-03-08 | 华北制药河北华民药业有限责任公司 | 一种头孢匹胺酸的精制方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111072688A (zh) | 2020-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101613359B (zh) | 头孢呋辛钠合成方法 | |
CN109575048B (zh) | 一种头孢噻肟钠的制备方法 | |
CN111072688B (zh) | 一种头孢匹胺酸的精制方法 | |
CN105669700A (zh) | 一种采用粒子过程晶体产品分子组装与形态优化技术的头孢呋辛钠新晶型化合物及制剂 | |
CN112535666B (zh) | 一种高稳定性注射用头孢呋辛钠粉针制剂的制备方法 | |
US9409940B2 (en) | Preparation process of erythromycin thiocyanate | |
CN101550146A (zh) | 一种盐酸头孢他美酯化合物及其制法 | |
CN109651402B (zh) | 一种头孢西酮钠的制备工艺 | |
CN109293680B (zh) | 一种头孢哌酮酸的制备方法 | |
CN109232610B (zh) | 一种头孢尼西二苄基乙二胺盐的精制方法 | |
CN111471057A (zh) | 一种溶媒结晶制备美洛西林钠的工艺 | |
CN103755726A (zh) | 一种头孢洛宁的精制提纯方法 | |
CN113387960B (zh) | 一种拉氧头孢钠中间体的精制方法 | |
CN105440054A (zh) | 一种制备高纯度头孢硫脒的工艺 | |
US8871927B2 (en) | Method for purifying Ceftizoxime sodium | |
CN104230956B (zh) | 一种头孢西丁的制备方法 | |
CN109354595B (zh) | 一种从Wittig反应精馏残液中回收三苯基氧膦的方法 | |
CN102898443B (zh) | 高收率超净高纯化头孢地嗪钠的精制方法 | |
CN109912625B (zh) | 一种降低头孢他啶杂质h的工艺方法 | |
CN108659008B (zh) | 头孢丙烯母液套用工艺 | |
CN106243128A (zh) | 一种头孢妥仑匹酯的精制方法 | |
CN112358489A (zh) | 一种青霉素亚砜工业化产品的生产方法 | |
CN108299469B (zh) | 一种头孢替安盐酸盐的制备方法 | |
CN110974832A (zh) | 一种注射用头孢孟多酯钠的制备方法 | |
CN111233894B (zh) | 一种头孢妥仑匹酯δ3异构体的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210809 Address after: 441141 Xiangcheng Economic Development Zone, Xiangcheng District, Xiangyang City, Hubei Province Patentee after: HUBEI LINGSHENG PHARMACEUTICAL Co.,Ltd. Address before: 441141 Xiangcheng Economic Development Zone, Xiangcheng District, Xiangyang City, Hubei Province Patentee before: HUBEI LINGSHENG PHARMACEUTICAL Co.,Ltd. Patentee before: WUHAN INSTITUTE OF TECHNOLOGY |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 441000 Xiangcheng Economic Development Zone, Xiangcheng District, Xiangyang City, Hubei Province Patentee after: Hubei Lingsheng Pharmaceutical Co.,Ltd. Country or region after: China Address before: 441141 Xiangcheng Economic Development Zone, Xiangcheng District, Xiangyang City, Hubei Province Patentee before: HUBEI LINGSHENG PHARMACEUTICAL CO.,LTD. Country or region before: China |
|
CP03 | Change of name, title or address |